Trials / Recruiting
RecruitingNCT05911750
Prevalence and Clinical Implications of HPV Infection in Male IBD Patients
Prevalence and Clinical Implications of Human Papillomavirus Infection in the Male Population With Inflammatory Bowel Disease
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 384 (estimated)
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
- Sex
- Male
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The study aims at describing the prevalence of Human Papillomavirus (HPV) infection in anal and oral samples of men with Inflammatory Bowel Disease (IBD) and detecting risk factors for the infection.
Detailed description
Male IBD patients attending the IBD Clinic of Hospital de la Santa Creu i Sant Pau will be screened for eligibility. Informed consent will be obtained from all eligible patients. An anal and oral swab will be performed on all patients to look for HPV infection (HPV DNA test) and cytologic alterations. Patients will be inspected to rule out the presence of HPV-related lesions. Moreover, a self-administered questionnaire will be completed by all enrolled patients. Information regarding IBD characteristics and treatment will be obtained. According to local practice, patients with anal or oral squamous intraepithelial lesions (ASIL) will be referred to a colorectal surgeon for further recommendations or treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Anal pap smear and oral swab for cytology and HPV testing | Anal and oral swab sampling for HPV detection (polymerase chain reaction) and cytology |
Timeline
- Start date
- 2023-02-12
- Primary completion
- 2026-01-31
- Completion
- 2026-06-01
- First posted
- 2023-06-22
- Last updated
- 2025-09-12
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05911750. Inclusion in this directory is not an endorsement.